Literature DB >> 34175654

SARM1 signaling mechanisms in the injured nervous system.

Shilpa Sambashivan1, Marc R Freeman2.   

Abstract

Axon degeneration is a prominent feature of the injured nervous system, occurs across neurological diseases, and drives functional loss in neural circuits. We have seen a paradigm shift in the last decade with the realization that injured axons are capable of actively driving their own destruction through the sterile-alpha and TIR motif containing 1 (SARM1) protein. Early studies of Wallerian degeneration highlighted a central role for NAD+ metabolites in axon survival, and this association has grown even stronger in recent years with a deeper understanding of SARM1 biology. Here, we review our current knowledge of SARM1 function in vivo and our evolving understanding of its complex architecture and regulation by injury-dependent changes in the local metabolic environment. The field is converging on a model whereby SARM1 acts as a sensor for metabolic changes that occur after injury and then drives catastrophic NAD+ loss to promote degeneration. However, a number of observations suggest that SARM1 biology is more complicated, and there remains much to learn about how SARM1 governs nervous system responses to injury or disease.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34175654      PMCID: PMC8387414          DOI: 10.1016/j.conb.2021.05.004

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   7.070


  50 in total

1.  SARM1 activation triggers axon degeneration locally via NAD⁺ destruction.

Authors:  Josiah Gerdts; E J Brace; Yo Sasaki; Aaron DiAntonio; Jeffrey Milbrandt
Journal:  Science       Date:  2015-04-23       Impact factor: 47.728

2.  Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken.

Authors:  A Ruf; J Mennissier de Murcia; G de Murcia; G E Schulz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

Review 3.  Pyridine Nucleotide Metabolites and Calcium Release from Intracellular Stores.

Authors:  Antony Galione; Kai-Ting Chuang
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

4.  Structural basis for the mechanistic understanding of human CD38-controlled multiple catalysis.

Authors:  Qun Liu; Irina A Kriksunov; Richard Graeff; Cyrus Munshi; Hon Cheung Lee; Quan Hao
Journal:  J Biol Chem       Date:  2006-09-02       Impact factor: 5.157

5.  Activation of autophagy during cell death requires the engulfment receptor Draper.

Authors:  Christina K McPhee; Mary A Logan; Marc R Freeman; Eric H Baehrecke
Journal:  Nature       Date:  2010-06-24       Impact factor: 49.962

6.  SARM1-specific motifs in the TIR domain enable NAD+ loss and regulate injury-induced SARM1 activation.

Authors:  Daniel W Summers; Daniel A Gibson; Aaron DiAntonio; Jeffrey Milbrandt
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

7.  Sarm1-mediated axon degeneration requires both SAM and TIR interactions.

Authors:  Josiah Gerdts; Daniel W Summers; Yo Sasaki; Aaron DiAntonio; Jeffrey Milbrandt
Journal:  J Neurosci       Date:  2013-08-14       Impact factor: 6.167

8.  dSarm/Sarm1 is required for activation of an injury-induced axon death pathway.

Authors:  Jeannette M Osterloh; Jing Yang; Timothy M Rooney; A Nicole Fox; Robert Adalbert; Eric H Powell; Amy E Sheehan; Michelle A Avery; Rachel Hackett; Mary A Logan; Jennifer M MacDonald; Jennifer S Ziegenfuss; Stefan Milde; Ying-Ju Hou; Carl Nathan; Aihao Ding; Robert H Brown; Laura Conforti; Michael Coleman; Marc Tessier-Lavigne; Stephan Züchner; Marc R Freeman
Journal:  Science       Date:  2012-06-07       Impact factor: 47.728

9.  SARM1 is a metabolic sensor activated by an increased NMN/NAD+ ratio to trigger axon degeneration.

Authors:  Matthew D Figley; Weixi Gu; Jeffrey D Nanson; Yun Shi; Yo Sasaki; Katie Cunnea; Alpeshkumar K Malde; Xinying Jia; Zhenyao Luo; Forhad K Saikot; Tamim Mosaiab; Veronika Masic; Stephanie Holt; Lauren Hartley-Tassell; Helen Y McGuinness; Mohammad K Manik; Todd Bosanac; Michael J Landsberg; Philip S Kerry; Mehdi Mobli; Robert O Hughes; Jeffrey Milbrandt; Bostjan Kobe; Aaron DiAntonio; Thomas Ve
Journal:  Neuron       Date:  2021-03-02       Impact factor: 17.173

10.  Pathological axonal death through a MAPK cascade that triggers a local energy deficit.

Authors:  Jing Yang; Zhuhao Wu; Nicolas Renier; David J Simon; Kunihiro Uryu; David S Park; Peter A Greer; Cathy Tournier; Roger J Davis; Marc Tessier-Lavigne
Journal:  Cell       Date:  2015-01-15       Impact factor: 41.582

View more
  3 in total

1.  Editorial: Neuroimmune Interactions in Peripheral Neuropathy.

Authors:  Jing Yang; Avraham Yaron; Kai Liu
Journal:  Front Mol Neurosci       Date:  2022-05-23       Impact factor: 6.261

2.  NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function.

Authors:  Fang Fang; Pei Zhuang; Xue Feng; Pingting Liu; Dong Liu; Haoliang Huang; Liang Li; Wei Chen; Liang Liu; Yang Sun; Haowen Jiang; Jiangbin Ye; Yang Hu
Journal:  Mol Ther       Date:  2022-01-31       Impact factor: 12.910

3.  Astrocytic SARM1 promotes neuroinflammation and axonal demyelination in experimental autoimmune encephalomyelitis through inhibiting GDNF signaling.

Authors:  Lingting Jin; Jingjing Zhang; Xin Hua; Xingxing Xu; Jia Li; Jiaojiao Wang; Mianxian Wang; Huitao Liu; Haoyu Qiu; Man Chen; Xu Zhang; Ying Wang; Zhihui Huang
Journal:  Cell Death Dis       Date:  2022-09-02       Impact factor: 9.685

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.